EC Neurology

Research Article Volume 16 Issue 10 - 2024

Parkinson's Disease in Sudan: Where are we now?

Ismat Babiker*

Department of Neurology, University of Medical Sciences and Technology (UMST), Sudan

*Corresponding Author: Ismat Babiker, Department of Neurology, University of Medical Sciences and Technology (UMST), Sudan.
Received: September 09, 2024; Published: September 25, 2024



Aim: To review the Parkinson’s disease (PD) literature in Sudan.

Methods: A narrative review of the literature was conducted in October 2022, using PubMed, Science Direct, and African Journals Online (AJOL) databases. Peer-reviewed published papers regarding Parkinson’s disease were retrieved from Sudan between 1957 and 2022. This review did not include animal studies, articles from South Sudan, or unpublished data. Brief communications and commentaries that do not generate new data were also excluded. The following keywords were used to search the literature: Parkinson's disease, "Parkinsonian," "parkinsonism," "tremor," "movement disorders," and " Sudan," "Sudanese."

Results: 146 articles were identified; seven of those met the inclusion criteria, including three case reports, one Cohort, and three cross-sectional studies. These articles contained information related to genetics (n = 5), clinical presentation of Parkinson’s disease (n = 1), and medication availability (n = 1).

Conclusion: The local literature on Parkinson's disease is scarce and mainly focuses on the genetic aspects of the condition. There is a need for epidemiological studies and articles highlighting responses to therapy and surgical interventions in the late stages.

Keywords: Parkinsonism; Parkinson's Disease; Tremor; Movement Disorders; Sudan

  1. Beitz JM. “Parkinson's disease: a review”. Frontiers in Bioscience-Scholar 1 (2014): 65-74.
  2. Elbaz A., et al. “Risk tables for Parkinsonism and Parkinson's disease”. Journal of Clinical Epidemiology 1 (2002): 25-31.
  3. Alhusseini RT., et al. “Clinical characteristics of Parkinson's disease in Sudanese patients attending Daoud Charity Clinic in 2020-2021”. Journal of the Neurological Sciences 429 (2021): 119594.
  4. Alhusseini RT., et al. “Prevalence of depression among Sudanese patients with Parkinson's disease attending Daoud charity clinic in 2020-2021”. Journal of the Neurological Sciences (2021): 429.
  5. Khalid K., et al. “Clinical presentation of Parkinson's disease among Sudanese patients”. Sudan Journal of Medical Sciences3 (2009).
  6. Hamid E., et al. “Availability of therapies and services for Parkinson's disease in Africa: A continent‐wide survey”. Movement Disorders10 (2021): 2393-407.
  7. Leutenegger AL., et al. “Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1”. Archives of Neurology9 (2006): 1257-1261.
  8. Ibrahim EA and Albasher SA. “PINK1 type of early onset Parkinson’s disease (EOPD) in Sudanese patients, 2018”. Sudan Journal of Medical Sciences3 (2019): 78-90.
  9. Bakhit Y., et al. “Methylation of alpha-synuclein in a Sudanese cohort”. Parkinsonism and Related Disorders 101 (2022): 6-8.
  10. Elsayed LE., et al. “A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson’s disease”. Annals of Neurology 2 (2016): 335-337.
  11. Cazeneuve C., et al. “A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson’s disease”. Neurogenetics3 (2009): 265-270.

Ismat Babiker., et al. “Parkinson's Disease in Sudan: Where are we now?”. EC Neurology  16.10 (2024): 01-04.